Immunicum AB's market cap is currently €31.69M. The company's EPS TTM is €-0.0404181; its P/E ratio is ―; Immunicum AB is scheduled to report earnings on August 21, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
